Invaluable Information and Insights on Generics and Biosimilars
GRx+BiosimsTM 2021 is the premier scientific and regulatory event for the U.S. generics and biosimilars industry, featuring timely programming relevant to technical, regulatory and policy professionals. GRx+Biosims 2021 will be a virtual conference to keep our community healthy and safe during this public health emergency. Speakers and attendees will be able to join globally from the comfort of their own space. The virtual experience will include showcasing content with keynotes, panel discussions and networking to be fully inclusive to all attendees. FDA officials joining us will include Drs. Jacqueline Corrigan-Curay, Elizabeth Miller, Sally Choe, Michael Kopcha, Donald Ashley, Gerald Dal Pan, Sarah Yim and more.
Registration and Fees
Early Bird Registration:
Early bird rates expire on October 1, 2021
AAM/ Biosimilars Council Member Fee: $799
Non-member Fee: $1099
Government Fee: $500
Standard Registration:
Registration fees starting on October 2 – November 10, 2021
AAM / Biosimilars Council Member Fee: $1,099
Nonmember Fee: $1,399
Government Fee: $500
Expo
Showcase your company at GRx+Biosims 2021. Don’t miss out on this highly interactive and professional business environment in which industry vendors can meet generic and biosimilars industry executives. We offer our exhibitors abundant networking time with industry decision-makers. For questions regarding exhibiting at the GRx+Biosims 2021 Conference, please contact Aquera Agee.
Sponsorship Opportunities
Raise your company profile by participating in this prestigious event. For more information regarding sponsorship levels and benefits contact Jennifer Soup.
